Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (R4873)
Received: 2 April 2020
Accepted: 3 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: The HEPAR PLuS study was approved by the Medical Ethics Committee of the University Medical Center Utrecht in 2014. Patients consent the use of their personal data for research purposes.
: Informed consent from the presented patient was obtained, as part of the HEPAR PLuS study
: MGEHL has acted as a consultant for BTG and Terumo. AJATB has acted as speaker for BTG, Sirtex Medical, and Terumo. The University Medical Center Utrecht (UMC Utrecht) receives royalties from Quirem Medical, producer of <sup>166</sup>Ho-microspheres, and receives research support from BTG, Terumo, and Quirem Medical.MS, RvR, and HWAMdJ declare no relationships with any companies whose products or services may be related to the subject matter of the article.